Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Detection of micrometastatic disease and monitoring of perioperative tumor cell dissemination in primary operable breast cancer patients using real-time quantitative reverse transcription-PCR.
Ismail MS, Wynendaele W, Aerts JL, Paridaens R, Gaafar R, Shakankiry N, Khaled HM, Christiaens MR, Wildiers H, Omar S, Vandekerckhove P, Van Oosterom AT. Ismail MS, et al. Among authors: wynendaele w. Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):196-201. doi: 10.1158/1078-0432.ccr-0515-2. Clin Cancer Res. 2004. PMID: 14734470
Real-time quantitative RT-PCR and detection of tumour cell dissemination in breast cancer patients: plasmid versus cell line dilutions.
Ismail MS, Wynendaele W, Aerts JL, Paridaens R, Van Mellaert L, Anné J, Gaafar R, Shakankiry N, Khaled HM, Christiaens MR, Omar S, Vandekerckhove P, Van Oosterom AT. Ismail MS, et al. Among authors: wynendaele w. Ann Oncol. 2003 Aug;14(8):1241-5. doi: 10.1093/annonc/mdg341. Ann Oncol. 2003. PMID: 12881386 Free article.
Neoadjuvant capecitabine and docetaxel (plus trastuzumab): an effective non-anthracycline-based chemotherapy regimen for patients with locally advanced breast cancer.
Wildiers H, Neven P, Christiaens MR, Squifflet P, Amant F, Weltens C, Smeets A, van Limbergen E, Debrock G, Renard V, Van Eenoo L, Wynendaele W, Paridaens R. Wildiers H, et al. Among authors: wynendaele w. Ann Oncol. 2011 Mar;22(3):588-594. doi: 10.1093/annonc/mdq406. Epub 2010 Aug 13. Ann Oncol. 2011. PMID: 20709813 Free article. Clinical Trial.
Weekly paclitaxel versus weekly docetaxel in elderly or frail patients with metastatic breast carcinoma: a randomized phase-II study of the Belgian Society of Medical Oncology.
Beuselinck B, Wildiers H, Wynendaele W, Dirix L, Kains JP, Paridaens R. Beuselinck B, et al. Among authors: wynendaele w. Crit Rev Oncol Hematol. 2010 Jul;75(1):70-7. doi: 10.1016/j.critrevonc.2009.07.001. Epub 2009 Aug 3. Crit Rev Oncol Hematol. 2010. PMID: 19651523 Clinical Trial.
Angiogenesis: possibilities for therapeutic interventions.
Wynendaele W, van Oosterom AT, Pawinski A, de Bruijn EA, Maes RA. Wynendaele W, et al. Pharm World Sci. 1998 Dec;20(6):225-35. doi: 10.1023/a:1008600603059. Pharm World Sci. 1998. PMID: 9972522 Review.
Vascular targeting of solid tumours: a major 'inverse' volume-response relationship following combretastatin A-4 phosphate treatment of rat rhabdomyosarcomas.
Landuyt W, Verdoes O, Darius DO, Drijkoningen M, Nuyts S, Theys J, Stockx L, Wynendaele W, Fowler JF, Maleux G, Van den Bogaert W, Anné J, van Oosterom A, Lambin P. Landuyt W, et al. Among authors: wynendaele w. Eur J Cancer. 2000 Sep;36(14):1833-43. doi: 10.1016/s0959-8049(00)00173-8. Eur J Cancer. 2000. PMID: 10974632
Multicenter phase II randomized trial evaluating antiangiogenic therapy with sunitinib as consolidation after objective response to taxane chemotherapy in women with HER2-negative metastatic breast cancer.
Wildiers H, Fontaine C, Vuylsteke P, Martens M, Canon JL, Wynendaele W, Focan C, De Greve J, Squifflet P, Paridaens R. Wildiers H, et al. Among authors: wynendaele w. Breast Cancer Res Treat. 2010 Sep;123(2):463-9. doi: 10.1007/s10549-010-1066-x. Epub 2010 Jul 22. Breast Cancer Res Treat. 2010. PMID: 20652398 Clinical Trial.
37 results